Professor Denise Kelly
Investment Advisor
Seventure Partners
Denise is an experienced life sciences investment advisor. Since joining Seventure Partners in 2015 she has focused on global healthcare investment opportunities spanning drug development, consumer health and wellness, healthspan and longevity, microbiome-based biotics and therapeutics. Previously, she held asenior research leadership positions at the University of Aberdeen and was Founder and CEO of GT Biologics Ltd, a pioneering microbiome therapeutics company subsequently acquired by 4D Pharma plc. She is an inventor on numerous European and US patents. Denise holds a BSc and PhD from Queen’s University Belfast and is Professor Emeritus at the University of Aberdeen.
